Poole Sandra (CIK 1619622) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-21). Recent activity: Buy TVTX (4,000 shares), Buy TVTX (6,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-21 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 4,000 | $0 |
| 2025-05-16 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 6,500 | $0 |
Source: SEC Form 4 filings · as of 2026-05-21